This 2007 update provides evidence-based guidelines for the prevention of cardiovascular disease in women, highlighting its massive global public health and economic impact.
Answers are grounded in this paper and cite their sources.
Demands immediate integration of sex-specific prevention into clinical practice; confirms the global burden necessitating dedicated guidelines and research.
WomenHeart: the National Coalition for Women with Heart Disease.W orldwide, cardiovascular disease (CVD) is the largest single cause of death among women, accounting for one third of all deaths. 1 In many countries, including the United States, more women than men die every year of CVD, a fact largely unknown by physicians.2,3 The public health impact of CVD in women is not related solely to the mortality rate, given that advances in science and medicine allow many women to survive heart disease.For example, in the United States, 38.2 million women (34%) are living with CVD, and the population at risk is even larger.2 In China, a country with a population of approximately 1.3 billion, the age-standardized prevalence rates of dyslipidemia and hypertension in women 35 to 74 years of age are 53% and 25%, respectively, which underscores the enormity of CVD as a global health issue and the need for prevention of risk factors in the first place.4 As life expectancy continues to increase and economies become more industrialized, the burden of CVD on women and the global economy will continue to increase.5 The human toll and economic impact of CVD are difficult to overstate.In the United States alone, $403 billion was estimated to be spent in 2006 on health care or in lost †Representation does not imply endorsement by the American College of Physicians.
No takes yet. Share an insight, caveat, or question.
Mosca et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: